KRYSTAL BIOTECH
Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.
KRYSTAL BIOTECH
Industry:
Biopharma Biotechnology Health Care
Founded:
2015-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.krystalbio.com
Total Employee:
11+
Status:
Active
Contact:
+1 412-586-5830
Email Addresses:
[email protected]
Total Funding:
386 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
21st.BIO
21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cache
Cache is advancing personalized medicine and digital data storage by making storage and access to biomolecules widely accessible.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Transcend
Transcend is committed to providing safe, reliable and high quality therapy systems to treat obstructive sleep apnea.
StabiLux Biosciences
StabiLux Biosciences produces high-brightness fluorophores for biomedical researchers.
Valkyrie GRP
Valkyrie GRP is a growth-oriented investment firm that focuses on team development, early distribution, and solid, value-added partnerships.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Krystal Biotech
Sun Pharma
Sun Pharma investment in Funding Round - Krystal Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-18 | Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors |
Official Site Inspections
http://www.krystalbio.com Semrush global rank: 2.12 M Semrush visits lastest month: 9.6 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Krystal Biotech"
Krystal Biotech, Inc. | Investors
Jun 3, 2025 Krystal Biotech, Inc. 2100 Wharton St. Suite #701. Pittsburgh, PA 15203. reception is in Suite #310. 412-586-5830See details»
Krystal Biotech Org Chart + Executive Team - The Official Board
Www.krystalbio.com. has 31 executives and 1 subsidiary +1 412 586 5830; Add an executive. Latest news on Krystal Biotech (KRYS) Anything missing? We search for you. Print or …See details»
Krystal Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 412-586-5830 Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that …See details»
Krystal Biotech CEO and Key Executive Team | Craft.co
Krystal Biotech's Chairman and Chief Executive Officer is Krish Krishnan. Other executives include Suma Krishnan, President, Research & Development; Kathryn Romano, Chief …See details»
Krystal Biotech Inc: Overview - GlobalData
Website www.krystalbio.com Telephone 1 412 5865830. No of Employees 275. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange KRYS (NASD) Revenue (2023) …See details»
Company - Krystal Biotech, Inc
Krystal Biotech is focused on the underlying genetic causes of these conditions and developing targeted therapies to provide long-term benefits for patients by pioneering the development of …See details»
News Releases | Investor Relations | Krystal Biotech, Inc.
Apr 28, 2025 Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full …See details»
Krystal Biotech - Work in biotech
Krystal Biotech is developing gene therapies to address skin diseases. Many debilitating skin diseases lack effective treatments. Krystal is solving this by introducing therapeutic genes into …See details»
Leadership - Krystal Biotech, Inc
Krish Krishnan Chairman & CEO. Krish Krishnan is an accomplished biotech executive. He was specifically involved in two successful IPOs (COO/CFO of New River Pharmaceuticals, Inc., …See details»
Who we are: Our vision: Our mission - krystalbio.com
Organization • Travel required - up to 25%. All interested applicants are required to submit their CV/ Resume and Cover Letter to [email protected]. Please note, applications submitted …See details»
Committee Composition | Krystal Biotech, Inc.
Krystal Biotech, Inc. 2100 Wharton St. Suite #701. Pittsburgh, PA 15203. reception is in Suite #310. 412-586-5830See details»
Krystal Biotech Announces Fourth Quarter and Full Year 2024
Feb 19, 2025 Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023. Full year revenues increased 473% to $290.5 million versus 2023 . CFF TDN granted …See details»
ir.krystalbio.com
Ir.krystalbio.comSee details»
Krystal Quality Bio | Excellence in Biological Sample Processing
Leading provider of high-quality biological sample processing and optimization for commercial and industrial applications.See details»
Krystal Biotech Announces First Quarter 2025 Financial and …
May 6, 2025 VYJUVEK approved in Europe for the treatment of DEB patients from birth. $88.2 million in 1Q VYJUVEK revenue and $429.4 million since launch in Q3 2023. Second …See details»
Krystal Biotech Appoints Andy Orth as Chief Commercial Officer
PITTSBURGH, May 03, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, announced today the …See details»
Science - Krystal Biotech, Inc
Redosable gene therapy holds the potential to provide long-lasting disease correction in a way that can be adjusted to meet the needs of an individual patient, and Krystal’s HSV‑1‑based …See details»
Krystal Biotech Appoints Laurent Goux as General Manager of …
In his latest role as Head of Global Strategic Marketing and Market Access at Galderma, Laurent led the global commercial organization through multiple successes and launches of …See details»
ANNUAL DESCRIPTION OF RYSTAL BIOTECH INC S …
Judgment and to effectuate change within the organization as necessary to establish and maintain the Compliance Program. 2. Written Standards Krystal's Compliance Program includes a …See details»
Patient Resources - Krystal Biotech, Inc
At Krystal, we believe it is a priority to lead with a ‘patients first’ mission. We strive to build enduring and supportive relationships within the patient community, and are committed to …See details»